Literature DB >> 11120443

Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy.

Y Ke1, B M Cohen, J Y Bang, M Yang, P F Renshaw.   

Abstract

A quantitative method to assess in vivo brain gamma-aminobutyric acid (GABA) levels is proposed using a J-resolved, two-dimensional (2D) magnetic resonance spectroscopy (MRS) technique. Localized, J-resolved 2D MR spectra were obtained from a 12-cm(3) voxel in the occipital lobe of 36 healthy volunteers (18 male and 18 female, age: 25.1+/-4.8 years). Based on phantom measurements, a GABA resonance peak located at 2.94 ppm, 7.45 Hz, in J-resolved 2D MRS overlaps the least with other resonance peaks which arise from N-acetylaspartate, choline, creatine, glutamate and glutamine. Measurements of this resonance peak yield in vivo GABA concentrations of 1.01+/-0.36 micromol/cm(3) for male and 1.16+/-0.43 micromol/cm(3) for female volunteers, without correction for T1 and T2 relaxation effects. These results are in good agreement with previously reported data and suggest that, with further development, 2D MRS may provide a practical means to estimate the concentration of this important neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120443     DOI: 10.1016/s0925-4927(00)00075-5

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  18 in total

Review 1.  GABA-based evaluation of neurologic conditions: MR spectroscopy.

Authors:  L M Levy; A J Degnan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

Review 2.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

3.  Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0 T magnetic resonance spectroscopy study.

Authors:  Constance M Moore; Megan Wardrop; Blaise deB Frederick; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2006-08-31       Impact factor: 4.530

Review 4.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 5.  GABAA receptor trafficking-mediated plasticity of inhibitory synapses.

Authors:  Bernhard Luscher; Thomas Fuchs; Casey L Kilpatrick
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

6.  Localized MRS reliability of in vivo glutamate at 3 T in shortened scan times: a feasibility study.

Authors:  J Eric Jensen; Randy P Auerbach; Angela Pisoni; Diego A Pizzagalli
Journal:  NMR Biomed       Date:  2017-07-21       Impact factor: 4.044

7.  Two-dimensional J-resolved proton MR spectroscopy and prior knowledge fitting (ProFit) in the frontal and parietal lobes of healthy volunteers: assessment of metabolite discrimination and general reproducibility.

Authors:  Andrew P Prescot; Perry F Renshaw
Journal:  J Magn Reson Imaging       Date:  2012-10-10       Impact factor: 4.813

8.  Human breast cancer metastases to the brain display GABAergic properties in the neural niche.

Authors:  Josh Neman; John Termini; Sharon Wilczynski; Nagarajan Vaidehi; Cecilia Choy; Claudia M Kowolik; Hubert Li; Amanda C Hambrecht; Eugene Roberts; Rahul Jandial
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

9.  Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.

Authors:  Chris C Streeter; John Hennen; Yong Ke; J Eric Jensen; Ofra Sarid-Segal; Leanne E Nassar; Clifford Knapp; Angela A Meyer; Tae Kwak; Perry F Renshaw; Domenic A Ciraulo
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

10.  Excitatory neurotransmitters in brain regions in interictal migraine patients.

Authors:  Andrew Prescot; Lino Becerra; Gautam Pendse; Shannon Tully; Eric Jensen; Richard Hargreaves; Perry Renshaw; Rami Burstein; David Borsook
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.